CHINA PHARMA HOLDINGS, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
China Pharma Holdings, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2024.
  • China Pharma Holdings, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$1.12M, a 43.8% decline year-over-year.
  • China Pharma Holdings, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$4.74M, a 52.5% decline year-over-year.
  • China Pharma Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$3.08M, a 22.5% increase from 2022.
  • China Pharma Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$3.97M, a 16.9% decline from 2021.
  • China Pharma Holdings, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.4M, a 18.6% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$4.74M -$1.12M -$340K -43.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-13
Q2 2024 -$4.4M -$1.44M -$845K -143% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-13
Q1 2024 -$3.56M -$956K -$480K -101% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-13
Q4 2023 -$3.08M -$1.23M +$32K +2.53% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$3.11M -$778K +$13.2K +1.67% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-13
Q2 2023 -$3.12M -$593K +$295K +33.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-13
Q1 2023 -$3.42M -$476K +$554K +53.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-13
Q4 2022 -$3.97M -$1.26M -$283K -28.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$3.69M -$791K +$35.9K +4.34% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$3.73M -$888K -$63.6K -7.72% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-13
Q1 2022 -$3.66M -$1.03M -$262K -34.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-13
Q4 2021 -$3.4M -$981K +$228K +18.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 -$3.63M -$827K +$183K +18.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$3.81M -$825K -$838K -6419% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-14
Q1 2021 -$2.97M -$767K -$106K -16.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-14
Q4 2020 -$2.87M -$1.21M +$17.5M +93.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-30
Q3 2020 -$20.4M -$1.01M -$309K -44.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$20.1M $13.1K +$851K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 -$20.9M -$661K -$243K -58.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$20.7M -$18.7M -$11.2M -147% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-26
Q3 2019 -$9.55M -$701K +$1.16M +62.2% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 -$10.7M -$838K +$170K +16.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-13
Q1 2019 -$10.9M -$418K -$124K -42.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-13
Q4 2018 -$10.8M -$7.59M +$6.24M +45.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$17M -$1.86M +$339K +15.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$17.3M -$1.01M +$1.28M +55.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$18.6M -$293K +$673K +69.6% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 -$19.3M -$13.8M -$10.4M -304% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-28
Q3 2017 -$8.88M -$2.2M -$446K -25.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$8.43M -$2.29M +$166K +6.76% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$8.6M -$967K +$586K +37.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q4 2016 -$9.18M -$3.43M +$12M +77.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$21.2M -$1.75M -$4.68M -160% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 -$16.5M -$2.45M -$3.58M -318% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$12.9M -$1.55M +$2.52M +61.8% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
Q4 2015 -$15.4M -$15.4M +$6.79M +30.6% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$22.2M $2.93M +$9.26M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-14
Q2 2015 -$31.5M $1.13M +$9.77M Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-11
Q1 2015 -$41.2M -$4.07M -$1.68M -70.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
Q4 2014 -$39.6M -$22.2M Oct 1, 2014 Dec 31, 2014 10-K 2016-03-30
Q3 2014 -$6.33M Jul 1, 2014 Sep 30, 2014 10-Q/A 2015-12-28
Q2 2014 -$8.64M Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-12-28
Q1 2014 -$2.39M -$2.68M -933% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-12-28
Q1 2013 $287K -$2.52M -89.8% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q1 2012 $17M $2.81M -$2.3M -45% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-14
Q4 2011 $19.3M $5.81M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 $3.29M -$2.62M -44.3% Jul 1, 2011 Sep 30, 2011 10-Q 2011-11-10
Q2 2011 $5.07M -$1.01M -16.7% Apr 1, 2011 Jun 30, 2011 10-Q/A 2011-09-06
Q1 2011 $5.1M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-14
Q3 2010 $5.91M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-10
Q2 2010 $6.08M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.